APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Orally Disintegrating Tablet Excipient

An orally disintegrating tablet or orally dissolving tablet (ODT) is a drug dosage form available for a limited range of over-the-counter (OTC) and prescription medications.An excipient is a pharmacologically inert adhesive substance used to bind the contents of a pill or tablet. This type of tablet separates in the mouth in contact with saliva, making it easy for a person to swallow the tablet without drinking water.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

An orally disintegrating tablet or orally dissolving tablet (ODT) is a drug dosage form available for a limited range of over-the-counter (OTC) and prescription medications.An excipient is a pharmacologically inert adhesive substance used to bind the contents of a pill or tablet. This type of tablet separates in the mouth in contact with saliva, making it easy for a person to swallow the tablet without drinking water.

Selected research

Market Analysis & Forecast

Global Orally Disintegrating Tablet Excipient Market Analysis and Forecast 2026-2032

Report ID 174020370220 December 2025190 pages

Choose your research edition.

Industry ResearchOrally Disintegrating Tablet Excipient Industry Research Report 2026131 pages · $2,950 USDIndustry Growth & TrendsGlobal Orally Disintegrating Tablet Excipient Industry Growth and Trends Forecast to 2032111 pages · $3,450 USDMarket StructureGlobal Orally Disintegrating Tablet Excipient Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Orally Disintegrating Tablet Excipient Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Orally Disintegrating Tablet Excipient Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

An orally disintegrating tablet or orally dissolving tablet (ODT) is a drug dosage form available for a limited range of over-the-counter (OTC) and prescription medications.An excipient is a pharmacologically inert adhesive substance used to bind the contents of a pill or tablet. This type of tablet separates in the mouth in contact with saliva, making it easy for a person to swallow the tablet without drinking water.

McePharma (Vivesa holding) was the global greatest company in Orally Disintegrating Tablet Excipient industry, with the revenue market Share of 3% , followed by BASF, JRS Pharma, Roquette, ABF Ingredients, DFE Pharma, Evonik, Merck KGaA, Ashland, Meggle Pharma, Shin-Etsu, Fuji Chemical Industries, Cargill Incorporated, Daicel Corporation, Anhui Sunhere Pharmaceutical.APAC is the largest Orally Disintegrating Tablet Excipient market with about 30% market share. Americas is follower, accounting for about 27% market share.

This report presents an overview of global market for Orally Disintegrating Tablet Excipient, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

Read the full market overview

This report researches the key producers of Orally Disintegrating Tablet Excipient, also provides the sales of main regions and countries. Of the upcoming market potential for Orally Disintegrating Tablet Excipient, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Orally Disintegrating Tablet Excipient sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Orally Disintegrating Tablet Excipient market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Orally Disintegrating Tablet Excipient sales, projected growth trends, production technology, application and end-user industry.

Orally Disintegrating Tablet Excipient Segment by Company

BASF

JRS Pharma

Roquette

ABF Ingredients

DFE Pharma

Evonik

Merck KGaA

Ashland

Meggle Pharma

Shin-Etsu

Fuji Chemical Industries

McePharma (Vivesa holding)

Cargill Incorporated

Daicel Corporation

Anhui Sunhere Pharmaceutical

Orally Disintegrating Tablet Excipient Segment by Type

Binders

Glidents

Diluents

Disintegrants

Others

Orally Disintegrating Tablet Excipient Segment by Application

Anti-Psychotics Drug

Anti-Epileptics Drug

Others

Orally Disintegrating Tablet Excipient Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Orally Disintegrating Tablet Excipient market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Orally Disintegrating Tablet Excipient and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Orally Disintegrating Tablet Excipient.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Orally Disintegrating Tablet Excipient in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Orally Disintegrating Tablet Excipient manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Orally Disintegrating Tablet Excipient sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Orally Disintegrating Tablet Excipient Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Binders Major Manufacturers Table 3. Glidents Major Manufacturers Table 4. Diluents Major Manufacturers Table 5. Disintegrants Major Manufacturers Table 6. Others Major Manufacturers Table 7. Global Orally Disintegrating Tablet Excipient Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 8. Anti-Psychotics Drug Major Manufacturers Table 9. Anti-Epileptics Drug Major Manufacturers Table 10. Others Major Manufacturers Table 11. Orally Disintegrating Tablet Excipient Industry Trends Table 12. Orally Disintegrating Tablet Excipient Industry Drivers Table 13. Orally Disintegrating Tablet Excipient Industry Opportunities and Challenges Table 14. Orally Disintegrating Tablet Excipient Industry Restraints Table 15. Global Orally Disintegrating Tablet Excipient Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 16. Global Orally Disintegrating Tablet Excipient Revenue by Region (2021-2026) & (US$ Million) Table 17. Global Orally Disintegrating Tablet Excipient Revenue by Region (2027-2032) & (US$ Million) Table 18. Global Orally Disintegrating Tablet Excipient Revenue Market Share by Region (2021-2026) Table 19. Global Orally Disintegrating Tablet Excipient Revenue Market Share by Region (2027-2032) Table 20. Global Orally Disintegrating Tablet Excipient Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K MT) Table 21. Global Orally Disintegrating Tablet Excipient Sales by Region (2021-2026) & (K MT) Table 22. Global Orally Disintegrating Tablet Excipient Sales by Region (2027-2032) & (K MT) Table 23. Global Orally Disintegrating Tablet Excipient Sales Market Share by Region (2021-2026) Table 24. Global Orally Disintegrating Tablet Excipient Sales Market Share by Region (2027-2032) Table 25. Global Orally Disintegrating Tablet Excipient Revenue by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Orally Disintegrating Tablet Excipient Revenue Market Share by Manufacturers (2021-2026) Table 27. Global Orally Disintegrating Tablet Excipient Sales by Manufacturers (US$ Million) & (2021-2026) Table 28. Global Orally Disintegrating Tablet Excipient Sales Market Share by Manufacturers (2021-2026) Table 29. Global Orally Disintegrating Tablet Excipient Sales Price (USD/MT) of Manufacturers (2021-2026) Table 30. Global Orally Disintegrating Tablet Excipient Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 31. Global Orally Disintegrating Tablet Excipient Key Manufacturers Manufacturing Sites & Headquarters Table 32. Global Orally Disintegrating Tablet Excipient Manufacturers, Product Type & Application Table 33. Global Orally Disintegrating Tablet Excipient Manufacturers' Establishment Date Table 34. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 35. Global Orally Disintegrating Tablet Excipient by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 36. Global Orally Disintegrating Tablet Excipient Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Orally Disintegrating Tablet Excipient Revenue by Type (2021-2026) & (US$ Million) Table 38. Global Orally Disintegrating Tablet Excipient Revenue by Type (2027-2032) & (US$ Million) Table 39. Global Orally Disintegrating Tablet Excipient Revenue Market Share by Type (2021-2026) Table 40. Global Orally Disintegrating Tablet Excipient Revenue Market Share by Type (2027-2032) Table 41. Global Orally Disintegrating Tablet Excipient Sales by Type 2021 VS 2025 VS 2032 (K MT) Table 42. Global Orally Disintegrating Tablet Excipient Sales by Type (2021-2026) & (K MT) Table 43. Global Orally Disintegrating Tablet Excipient Sales by Type (2027-2032) & (K MT) Table 44. Global Orally Disintegrating Tablet Excipient Sales Market Share by Type (2021-2026) Table 45. Global Orally Disintegrating Tablet Excipient Sales Market Share by Type (2027-2032) Table 46. Global Orally Disintegrating Tablet Excipient Price by Type (2021-2026) & (USD/MT) Table 47. Global Orally Disintegrating Tablet Excipient Price by Type (2027-2032) & (USD/MT) Table 48. Global Orally Disintegrating Tablet Excipient Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Orally Disintegrating Tablet Excipient Revenue by Application (2021-2026) & (US$ Million) Table 50. Global Orally Disintegrating Tablet Excipient Revenue by Application (2027-2032) & (US$ Million) Table 51. Global Orally Disintegrating Tablet Excipient Revenue Market Share by Application (2021-2026) Table 52. Global Orally Disintegrating Tablet Excipient Revenue Market Share by Application (2027-2032) Table 53. Global Orally Disintegrating Tablet Excipient Sales by Application 2021 VS 2025 VS 2032 (K MT) Table 54. Global Orally Disintegrating Tablet Excipient Sales by Application (2021-2026) & (K MT) Table 55. Global Orally Disintegrating Tablet Excipient Sales by Application (2027-2032) & (K MT) Table 56. Global Orally Disintegrating Tablet Excipient Sales Market Share by Application (2021-2026) Table 57. Global Orally Disintegrating Tablet Excipient Sales Market Share by Application (2027-2032) Table 58. Global Orally Disintegrating Tablet Excipient Price by Application (2021-2026) & (USD/MT) Table 59. Global Orally Disintegrating Tablet Excipient Price by Application (2027-2032) & (USD/MT) Table 60. BASF Company Information Table 61. BASF Business Overview Table 62. BASF Orally Disintegrating Tablet Excipient Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 63. BASF Orally Disintegrating Tablet Excipient Product Portfolio Table 64. BASF Recent Development Table 65. JRS Pharma Company Information Table 66. JRS Pharma Business Overview Table 67. JRS Pharma Orally Disintegrating Tablet Excipient Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 68. JRS Pharma Orally Disintegrating Tablet Excipient Product Portfolio Table 69. JRS Pharma Recent Development Table 70. Roquette Company Information Table 71. Roquette Business Overview Table 72. Roquette Orally Disintegrating Tablet Excipient Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 73. Roquette Orally Disintegrating Tablet Excipient Product Portfolio Table 74. Roquette Recent Development Table 75. ABF Ingredients Company Information Table 76. ABF Ingredients Business Overview Table 77. ABF Ingredients Orally Disintegrating Tablet Excipient Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 78. ABF Ingredients Orally Disintegrating Tablet Excipient Product Portfolio Table 79. ABF Ingredients Recent Development Table 80. DFE Pharma Company Information Table 81. DFE Pharma Business Overview Table 82. DFE Pharma Orally Disintegrating Tablet Excipient Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 83. DFE Pharma Orally Disintegrating Tablet Excipient Product Portfolio Table 84. DFE Pharma Recent Development Table 85. Evonik Company Information Table 86. Evonik Business Overview Table 87. Evonik Orally Disintegrating Tablet Excipient Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 88. Evonik Orally Disintegrating Tablet Excipient Product Portfolio Table 89. Evonik Recent Development Table 90. Merck KGaA Company Information Table 91. Merck KGaA Business Overview Table 92. Merck KGaA Orally Disintegrating Tablet Excipient Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 93. Merck KGaA Orally Disintegrating Tablet Excipient Product Portfolio Table 94. Merck KGaA Recent Development Table 95. Ashland Company Information Table 96. Ashland Business Overview Table 97. Ashland Orally Disintegrating Tablet Excipient Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 98. Ashland Orally Disintegrating Tablet Excipient Product Portfolio Table 99. Ashland Recent Development Table 100. Meggle Pharma Company Information Table 101. Meggle Pharma Business Overview Table 102. Meggle Pharma Orally Disintegrating Tablet Excipient Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 103. Meggle Pharma Orally Disintegrating Tablet Excipient Product Portfolio Table 104. Meggle Pharma Recent Development Table 105. Shin-Etsu Company Information Table 106. Shin-Etsu Business Overview Table 107. Shin-Etsu Orally Disintegrating Tablet Excipient Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 108. Shin-Etsu Orally Disintegrating Tablet Excipient Product Portfolio Table 109. Shin-Etsu Recent Development Table 110. Fuji Chemical Industries Company Information Table 111. Fuji Chemical Industries Business Overview Table 112. Fuji Chemical Industries Orally Disintegrating Tablet Excipient Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 113. Fuji Chemical Industries Orally Disintegrating Tablet Excipient Product Portfolio Table 114. Fuji Chemical Industries Recent Development Table 115. McePharma (Vivesa holding) Company Information Table 116. McePharma (Vivesa holding) Business Overview Table 117. McePharma (Vivesa holding) Orally Disintegrating Tablet Excipient Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 118. McePharma (Vivesa holding) Orally Disintegrating Tablet Excipient Product Portfolio Table 119. McePharma (Vivesa holding) Recent Development Table 120. Cargill Incorporated Company Information Table 121. Cargill Incorporated Business Overview Table 122. Cargill Incorporated Orally Disintegrating Tablet Excipient Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 123. Cargill Incorporated Orally Disintegrating Tablet Excipient Product Portfolio Table 124. Cargill Incorporated Recent Development Table 125. Daicel Corporation Company Information Table 126. Daicel Corporation Business Overview Table 127. Daicel Corporation Orally Disintegrating Tablet Excipient Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 128. Daicel Corporation Orally Disintegrating Tablet Excipient Product Portfolio Table 129. Daicel Corporation Recent Development Table 130. Anhui Sunhere Pharmaceutical Company Information Table 131. Anhui Sunhere Pharmaceutical Business Overview Table 132. Anhui Sunhere Pharmaceutical Orally Disintegrating Tablet Excipient Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 133. Anhui Sunhere Pharmaceutical Orally Disintegrating Tablet Excipient Product Portfolio Table 134. Anhui Sunhere Pharmaceutical Recent Development Table 135. North America Orally Disintegrating Tablet Excipient Revenue by Type (2021-2026) & (US$ Million) Table 136. North America Orally Disintegrating Tablet Excipient Revenue by Type (2027-2032) & (US$ Million) Table 137. North America Orally Disintegrating Tablet Excipient Sales by Type (2021-2026) & (K MT) Table 138. North America Orally Disintegrating Tablet Excipient Sales by Type (2027-2032) & (K MT) Table 139. North America Orally Disintegrating Tablet Excipient Sales Price by Type (2021-2026) & (USD/MT) Table 140. North America Orally Disintegrating Tablet Excipient Sales Price by Type (2027-2032) & (USD/MT) Table 141. North America Orally Disintegrating Tablet Excipient Revenue by Application (2021-2026) & (US$ Million) Table 142. North America Orally Disintegrating Tablet Excipient Revenue by Application (2027-2032) & (US$ Million) Table 143. North America Orally Disintegrating Tablet Excipient Sales by Application (2021-2026) & (K MT) Table 144. North America Orally Disintegrating Tablet Excipient Sales by Application (2027-2032) & (K MT) Table 145. North America Orally Disintegrating Tablet Excipient Sales Price by Application (2021-2026) & (USD/MT) Table 146. North America Orally Disintegrating Tablet Excipient Sales Price by Application (2027-2032) & (USD/MT) Table 147. North America Orally Disintegrating Tablet Excipient Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 148. North America Orally Disintegrating Tablet Excipient Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 149. North America Orally Disintegrating Tablet Excipient Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 150. North America Orally Disintegrating Tablet Excipient Sales by Country (2021 VS 2025 VS 2032) & (K MT) Table 151. North America Orally Disintegrating Tablet Excipient Sales by Country (2021-2026) & (K MT) Table 152. North America Orally Disintegrating Tablet Excipient Sales by Country (2027-2032) & (K MT) Table 153. North America Orally Disintegrating Tablet Excipient Sales Price by Country (2021-2026) & (USD/MT) Table 154. North America Orally Disintegrating Tablet Excipient Sales Price by Country (2027-2032) & (USD/MT) Table 155. United States Orally Disintegrating Tablet Excipient Revenue (2021-2032) & (US$ Million) Table 156. Canada Orally Disintegrating Tablet Excipient Revenue (2021-2032) & (US$ Million) Table 157. Mexico Orally Disintegrating Tablet Excipient Revenue (2021-2032) & (US$ Million) Table 158. Europe Orally Disintegrating Tablet Excipient Revenue by Type (2021-2026) & (US$ Million) Table 159. Europe Orally Disintegrating Tablet Excipient Revenue by Type (2027-2032) & (US$ Million) Table 160. Europe Orally Disintegrating Tablet Excipient Sales by Type (2021-2026) & (K MT) Table 161. Europe Orally Disintegrating Tablet Excipient Sales by Type (2027-2032) & (K MT) Table 162. Europe Orally Disintegrating Tablet Excipient Sales Price by Type (2021-2026) & (USD/MT) Table 163. Europe Orally Disintegrating Tablet Excipient Sales Price by Type (2027-2032) & (USD/MT) Table 164. Europe Orally Disintegrating Tablet Excipient Revenue by Application (2021-2026) & (US$ Million) Table 165. Europe Orally Disintegrating Tablet Excipient Revenue by Application (2027-2032) & (US$ Million) Table 166. Europe Orally Disintegrating Tablet Excipient Sales by Application (2021-2026) & (K MT) Table 167. Europe Orally Disintegrating Tablet Excipient Sales by Application (2027-2032) & (K MT) Table 168. Europe Orally Disintegrating Tablet Excipient Sales Price by Application (2021-2026) & (USD/MT) Table 169. Europe Orally Disintegrating Tablet Excipient Sales Price by Application (2027-2032) & (USD/MT) Table 170. Europe Orally Disintegrating Tablet Excipient Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 171. Europe Orally Disintegrating Tablet Excipient Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 172. Europe Orally Disintegrating Tablet Excipient Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 173. Europe Orally Disintegrating Tablet Excipient Sales by Country (2021 VS 2025 VS 2032) & (K MT) Table 174. Europe Orally Disintegrating Tablet Excipient Sales by Country (2021-2026) & (K MT) Table 175. Europe Orally Disintegrating Tablet Excipient Sales by Country (2027-2032) & (K MT) Table 176. Europe Orally Disintegrating Tablet Excipient Sales Price by Country (2021-2026) & (USD/MT) Table 177. Europe Orally Disintegrating Tablet Excipient Sales Price by Country (2027-2032) & (USD/MT) Table 178. Germany Orally Disintegrating Tablet Excipient Revenue (2021-2032) & (US$ Million) Table 179. France Orally Disintegrating Tablet Excipient Revenue (2021-2032) & (US$ Million) Table 180. U.K. Orally Disintegrating Tablet Excipient Revenue (2021-2032) & (US$ Million) Table 181. Italy Orally Disintegrating Tablet Excipient Revenue (2021-2032) & (US$ Million) Table 182. Russia Orally Disintegrating Tablet Excipient Revenue (2021-2032) & (US$ Million) Table 183. Spain Orally Disintegrating Tablet Excipient Revenue (2021-2032) & (US$ Million) Table 184. Netherlands Orally Disintegrating Tablet Excipient Revenue (2021-2032) & (US$ Million) Table 185. Switzerland Orally Disintegrating Tablet Excipient Revenue (2021-2032) & (US$ Million) Table 186. Sweden Orally Disintegrating Tablet Excipient Revenue (2021-2032) & (US$ Million) Table 187. Poland Orally Disintegrating Tablet Excipient Revenue (2021-2032) & (US$ Million) Table 188. China Orally Disintegrating Tablet Excipient Revenue by Type (2021-2026) & (US$ Million) Table 189. China Orally Disintegrating Tablet Excipient Revenue by Type (2027-2032) & (US$ Million) Table 190. China Orally Disintegrating Tablet Excipient Sales by Type (2021-2026) & (K MT) Table 191. China Orally Disintegrating Tablet Excipient Sales by Type (2027-2032) & (K MT) Table 192. China Orally Disintegrating Tablet Excipient Sales Price by Type (2021-2026) & (USD/MT) Table 193. China Orally Disintegrating Tablet Excipient Sales Price by Type (2027-2032) & (USD/MT) Table 194. China Orally Disintegrating Tablet Excipient Revenue by Application (2021-2026) & (US$ Million) Table 195. China Orally Disintegrating Tablet Excipient Revenue by Application (2027-2032) & (US$ Million) Table 196. China Orally Disintegrating Tablet Excipient Sales by Application (2021-2026) & (K MT) Table 197. China Orally Disintegrating Tablet Excipient Sales by Application (2027-2032) & (K MT) Table 198. China Orally Disintegrating Tablet Excipient Sales Price by Application (2021-2026) & (USD/MT) Table 199. China Orally Disintegrating Tablet Excipient Sales Price by Application (2027-2032) & (USD/MT) Table 200. Asia Orally Disintegrating Tablet Excipient Revenue by Type (2021-2026) & (US$ Million) Table 201. Asia Orally Disintegrating Tablet Excipient Revenue by Type (2027-2032) & (US$ Million) Table 202. Asia Orally Disintegrating Tablet Excipient Sales by Type (2021-2026) & (K MT) Table 203. Asia Orally Disintegrating Tablet Excipient Sales by Type (2027-2032) & (K MT) Table 204. Asia Orally Disintegrating Tablet Excipient Sales Price by Type (2021-2026) & (USD/MT) Table 205. Asia Orally Disintegrating Tablet Excipient Sales Price by Type (2027-2032) & (USD/MT) Table 206. Asia Orally Disintegrating Tablet Excipient Revenue by Application (2021-2026) & (US$ Million) Table 207. Asia Orally Disintegrating Tablet Excipient Revenue by Application (2027-2032) & (US$ Million) Table 208. Asia Orally Disintegrating Tablet Excipient Sales by Application (2021-2026) & (K MT) Table 209. Asia Orally Disintegrating Tablet Excipient Sales by Application (2027-2032) & (K MT) Table 210. Asia Orally Disintegrating Tablet Excipient Sales Price by Application (2021-2026) & (USD/MT) Table 211. Asia Orally Disintegrating Tablet Excipient Sales Price by Application (2027-2032) & (USD/MT) Table 212. Asia Orally Disintegrating Tablet Excipient Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 213. Asia Orally Disintegrating Tablet Excipient Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 214. Asia Orally Disintegrating Tablet Excipient Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 215. Asia Orally Disintegrating Tablet Excipient Sales by Country (2021 VS 2025 VS 2032) & (K MT) Table 216. Asia Orally Disintegrating Tablet Excipient Sales by Country (2021-2026) & (K MT) Table 217. Asia Orally Disintegrating Tablet Excipient Sales by Country (2027-2032) & (K MT) Table 218. Asia Orally Disintegrating Tablet Excipient Sales Price by Country (2021-2026) & (USD/MT) Table 219. Asia Orally Disintegrating Tablet Excipient Sales Price by Country (2027-2032) & (USD/MT) Table 220. Japan Orally Disintegrating Tablet Excipient Revenue (2021-2032) & (US$ Million) Table 221. South Korea Orally Disintegrating Tablet Excipient Revenue (2021-2032) & (US$ Million) Table 222. India Orally Disintegrating Tablet Excipient Revenue (2021-2032) & (US$ Million) Table 223. Australia Orally Disintegrating Tablet Excipient Revenue (2021-2032) & (US$ Million) Table 224. Taiwan Orally Disintegrating Tablet Excipient Revenue (2021-2032) & (US$ Million) Table 225. Southeast Asia Orally Disintegrating Tablet Excipient Revenue (2021-2032) & (US$ Million) Table 226. SAMEA Orally Disintegrating Tablet Excipient Revenue by Type (2021-2026) & (US$ Million) Table 227. SAMEA Orally Disintegrating Tablet Excipient Revenue by Type (2027-2032) & (US$ Million) Table 228. SAMEA Orally Disintegrating Tablet Excipient Sales by Type (2021-2026) & (K MT) Table 229. SAMEA Orally Disintegrating Tablet Excipient Sales by Type (2027-2032) & (K MT) Table 230. SAMEA Orally Disintegrating Tablet Excipient Sales Price by Type (2021-2026) & (USD/MT) Table 231. SAMEA Orally Disintegrating Tablet Excipient Sales Price by Type (2027-2032) & (USD/MT) Table 232. SAMEA Orally Disintegrating Tablet Excipient Revenue by Application (2021-2026) & (US$ Million) Table 233. SAMEA Orally Disintegrating Tablet Excipient Revenue by Application (2027-2032) & (US$ Million) Table 234. SAMEA Orally Disintegrating Tablet Excipient Sales by Application (2021-2026) & (K MT) Table 235. SAMEA Orally Disintegrating Tablet Excipient Sales by Application (2027-2032) & (K MT) Table 236. SAMEA Orally Disintegrating Tablet Excipient Sales Price by Application (2021-2026) & (USD/MT) Table 237. SAMEA Orally Disintegrating Tablet Excipient Sales Price by Application (2027-2032) & (USD/MT) Table 238. SAMEA Orally Disintegrating Tablet Excipient Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 239. SAMEA Orally Disintegrating Tablet Excipient Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 240. SAMEA Orally Disintegrating Tablet Excipient Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 241. SAMEA Orally Disintegrating Tablet Excipient Sales by Country (2021 VS 2025 VS 2032) & (K MT) Table 242. SAMEA Orally Disintegrating Tablet Excipient Sales by Country (2021-2026) & (K MT) Table 243. SAMEA Orally Disintegrating Tablet Excipient Sales by Country (2027-2032) & (K MT) Table 244. SAMEA Orally Disintegrating Tablet Excipient Sales Price by Country (2021-2026) & (USD/MT) Table 245. SAMEA Orally Disintegrating Tablet Excipient Sales Price by Country (2027-2032) & (USD/MT) Table 246. Brazil Orally Disintegrating Tablet Excipient Revenue (2021-2032) & (US$ Million) Table 247. Argentina Orally Disintegrating Tablet Excipient Revenue (2021-2032) & (US$ Million) Table 248. Chile Orally Disintegrating Tablet Excipient Revenue (2021-2032) & (US$ Million) Table 249. Colombia Orally Disintegrating Tablet Excipient Revenue (2021-2032) & (US$ Million) Table 250. Peru Orally Disintegrating Tablet Excipient Revenue (2021-2032) & (US$ Million) Table 251. Saudi Arabia Orally Disintegrating Tablet Excipient Revenue (2021-2032) & (US$ Million) Table 252. Israel Orally Disintegrating Tablet Excipient Revenue (2021-2032) & (US$ Million) Table 253. UAE Orally Disintegrating Tablet Excipient Revenue (2021-2032) & (US$ Million) Table 254. Turkey Orally Disintegrating Tablet Excipient Revenue (2021-2032) & (US$ Million) Table 255. Iran Orally Disintegrating Tablet Excipient Revenue (2021-2032) & (US$ Million) Table 256. Egypt Orally Disintegrating Tablet Excipient Revenue (2021-2032) & (US$ Million) Table 257. Key Raw Materials Table 258. Raw Materials Key Suppliers Table 259. Orally Disintegrating Tablet Excipient Distributors List Table 260. Orally Disintegrating Tablet Excipient Customers List Table 261. Research Programs/Design for This Report Table 262. Authors List of This Report Table 263. Secondary Sources Table 264. Primary Sources List of Figures Figure 1. Orally Disintegrating Tablet Excipient Image Figure 2. Global Orally Disintegrating Tablet Excipient Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Orally Disintegrating Tablet Excipient Market Size Share 2021 VS 2025 VS 2032 Figure 4. Binders Image Figure 5. Glidents Image Figure 6. Diluents Image Figure 7. Disintegrants Image Figure 8. Others Image Figure 9. Global Orally Disintegrating Tablet Excipient Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 10. Global Orally Disintegrating Tablet Excipient Market Size Share 2021 VS 2025 VS 2032 Figure 11. Anti-Psychotics Drug Image Figure 12. Anti-Epileptics Drug Image Figure 13. Others Image Figure 14. Global Orally Disintegrating Tablet Excipient Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Orally Disintegrating Tablet Excipient Revenue (2021-2032) & (US$ Million) Figure 16. Global Orally Disintegrating Tablet Excipient Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 17. Global Orally Disintegrating Tablet Excipient Revenue Market Share by Region: 2025 Versus 2032 Figure 18. Global Orally Disintegrating Tablet Excipient Revenue Market Share by Region (2021-2032) Figure 19. Global Orally Disintegrating Tablet Excipient Sales (2021-2032) & (K MT) Figure 20. Global Orally Disintegrating Tablet Excipient Sales by Region: 2021 VS 2025 VS 2032 (K MT) Figure 21. Global Orally Disintegrating Tablet Excipient Sales Market Share by Region (2021-2032) Figure 22. US & Canada & Mexico Orally Disintegrating Tablet Excipient Sales YoY (2021-2032) & (K MT) Figure 23. Europe Orally Disintegrating Tablet Excipient Sales YoY (2021-2032) & (K MT) Figure 24. China Orally Disintegrating Tablet Excipient Sales YoY (2021-2032) & (K MT) Figure 25. Asia (Excluding China) Orally Disintegrating Tablet Excipient Sales YoY (2021-2032) & (K MT) Figure 26. South America, Middle East and Africa Orally Disintegrating Tablet Excipient Sales YoY (2021-2032) & (K MT) Figure 27. Global Orally Disintegrating Tablet Excipient Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 28. Global Orally Disintegrating Tablet Excipient Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 29. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 30. Global Orally Disintegrating Tablet Excipient Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 31. Global Orally Disintegrating Tablet Excipient Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Orally Disintegrating Tablet Excipient Revenue Market Share by Type (2021-2032) Figure 33. Global Orally Disintegrating Tablet Excipient Sales by Type (2021 VS 2025 VS 2032) & (K MT) Figure 34. Global Orally Disintegrating Tablet Excipient Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 35. Global Orally Disintegrating Tablet Excipient Sales Market Share by Type (2021-2032) Figure 36. Global Orally Disintegrating Tablet Excipient Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 37. Global Orally Disintegrating Tablet Excipient Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Orally Disintegrating Tablet Excipient Revenue Market Share by Application (2021-2032) Figure 39. Global Orally Disintegrating Tablet Excipient Sales by Application (2021 VS 2025 VS 2032) & (K MT) Figure 40. Global Orally Disintegrating Tablet Excipient Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 41. Global Orally Disintegrating Tablet Excipient Sales Market Share by Application (2021-2032) Figure 42. North America Orally Disintegrating Tablet Excipient Revenue Share by Type (2021-2032) Figure 43. North America Orally Disintegrating Tablet Excipient Sales Share by Type (2021-2032) Figure 44. North America Orally Disintegrating Tablet Excipient Revenue Share by Application (2021-2032) Figure 45. North America Orally Disintegrating Tablet Excipient Sales Share by Application (2021-2032) Figure 46. North America Orally Disintegrating Tablet Excipient Revenue Share by Country (2021-2032) Figure 47. North America Orally Disintegrating Tablet Excipient Sales Share by Country (2021-2032) Figure 48. Europe Orally Disintegrating Tablet Excipient Revenue Share by Type (2021-2032) Figure 49. Europe Orally Disintegrating Tablet Excipient Sales Share by Type (2021-2032) Figure 50. Europe Orally Disintegrating Tablet Excipient Revenue Share by Application (2021-2032) Figure 51. Europe Orally Disintegrating Tablet Excipient Sales Share by Application (2021-2032) Figure 52. Europe Orally Disintegrating Tablet Excipient Revenue Share by Country (2021-2032) Figure 53. Europe Orally Disintegrating Tablet Excipient Sales Share by Country (2021-2032) Figure 54. China Orally Disintegrating Tablet Excipient Revenue Share by Type (2021-2032) Figure 55. China Orally Disintegrating Tablet Excipient Sales Share by Type (2021-2032) Figure 56. China Orally Disintegrating Tablet Excipient Revenue Share by Application (2021-2032) Figure 57. China Orally Disintegrating Tablet Excipient Sales Share by Application (2021-2032) Figure 58. Asia Orally Disintegrating Tablet Excipient Revenue Share by Type (2021-2032) Figure 59. Asia Orally Disintegrating Tablet Excipient Sales Share by Type (2021-2032) Figure 60. Asia Orally Disintegrating Tablet Excipient Revenue Share by Application (2021-2032) Figure 61. Asia Orally Disintegrating Tablet Excipient Sales Share by Application (2021-2032) Figure 62. Asia Orally Disintegrating Tablet Excipient Revenue Share by Country (2021-2032) Figure 63. Asia Orally Disintegrating Tablet Excipient Sales Share by Country (2021-2032) Figure 64. SAMEA Orally Disintegrating Tablet Excipient Revenue Share by Type (2021-2032) Figure 65. SAMEA Orally Disintegrating Tablet Excipient Sales Share by Type (2021-2032) Figure 66. SAMEA Orally Disintegrating Tablet Excipient Revenue Share by Application (2021-2032) Figure 67. SAMEA Orally Disintegrating Tablet Excipient Sales Share by Application (2021-2032) Figure 68. SAMEA Orally Disintegrating Tablet Excipient Revenue Share by Country (2021-2032) Figure 69. SAMEA Orally Disintegrating Tablet Excipient Sales Share by Country (2021-2032) Figure 70. Orally Disintegrating Tablet Excipient Value Chain Figure 71. Manufacturing Cost Structure Figure 72. Orally Disintegrating Tablet Excipient Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Years Considered Figure 76. Research Process Figure 77. Key Executives Interviewed

Scope & coverage.

Types
  • Binders
  • Glidents
  • Diluents
  • Disintegrants
  • Others
Applications
  • Anti-Psychotics Drug
  • Anti-Epileptics Drug
  • Others
Companies covered
  • BASF
  • JRS Pharma
  • Roquette
  • ABF Ingredients
  • DFE Pharma
  • Evonik
  • Merck KGaA
  • Ashland
  • Meggle Pharma
  • Shin-Etsu
  • Fuji Chemical Industries
  • McePharma (Vivesa holding)
  • Cargill Incorporated
  • Daicel Corporation
  • Anhui Sunhere Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Orally Disintegrating Tablet Excipient Market by Type
  3. 1.2.1 Global Orally Disintegrating Tablet Excipient Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Binders
  5. 1.2.3 Glidents
  6. 1.2.4 Diluents
  7. 1.2.5 Disintegrants
  8. 1.2.6 Others
  9. 1.3 Orally Disintegrating Tablet Excipient Market by Application
  10. 1.3.1 Global Orally Disintegrating Tablet Excipient Market Size by Application, 2021 VS 2025 VS 2032
  11. 1.3.2 Anti-Psychotics Drug
  12. 1.3.3 Anti-Epileptics Drug
  13. 1.3.4 Others
  14. 1.4 Assumptions and Limitations
  15. 1.5 Study Goals and Objectives
2 Orally Disintegrating Tablet Excipient Market Dynamics
  1. 2.1 Orally Disintegrating Tablet Excipient Industry Trends
  2. 2.2 Orally Disintegrating Tablet Excipient Industry Drivers
  3. 2.3 Orally Disintegrating Tablet Excipient Industry Opportunities and Challenges
  4. 2.4 Orally Disintegrating Tablet Excipient Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Orally Disintegrating Tablet Excipient Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Orally Disintegrating Tablet Excipient Revenue by Region
  3. 3.2.1 Global Orally Disintegrating Tablet Excipient Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Orally Disintegrating Tablet Excipient Revenue by Region (2021-2026)
  5. 3.2.3 Global Orally Disintegrating Tablet Excipient Revenue by Region (2027-2032)
  6. 3.2.4 Global Orally Disintegrating Tablet Excipient Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Orally Disintegrating Tablet Excipient Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Orally Disintegrating Tablet Excipient Sales by Region
  9. 3.4.1 Global Orally Disintegrating Tablet Excipient Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Orally Disintegrating Tablet Excipient Sales by Region (2021-2026)
  11. 3.4.3 Global Orally Disintegrating Tablet Excipient Sales by Region (2027-2032)
  12. 3.4.4 Global Orally Disintegrating Tablet Excipient Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Orally Disintegrating Tablet Excipient Revenue by Manufacturers
  2. 4.1.1 Global Orally Disintegrating Tablet Excipient Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Orally Disintegrating Tablet Excipient Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Orally Disintegrating Tablet Excipient Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Orally Disintegrating Tablet Excipient Sales by Manufacturers
  6. 4.2.1 Global Orally Disintegrating Tablet Excipient Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Orally Disintegrating Tablet Excipient Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Orally Disintegrating Tablet Excipient Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Orally Disintegrating Tablet Excipient Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Orally Disintegrating Tablet Excipient Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Orally Disintegrating Tablet Excipient Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Orally Disintegrating Tablet Excipient Manufacturers, Product Type & Application
  13. 4.7 Global Orally Disintegrating Tablet Excipient Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Orally Disintegrating Tablet Excipient Market CR5 and HHI
  16. 4.8.2 2025 Orally Disintegrating Tablet Excipient Tier 1, Tier 2, and Tier 3
5 Orally Disintegrating Tablet Excipient Market by Type
  1. 5.1 Global Orally Disintegrating Tablet Excipient Revenue by Type
  2. 5.1.1 Global Orally Disintegrating Tablet Excipient Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Orally Disintegrating Tablet Excipient Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Orally Disintegrating Tablet Excipient Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Orally Disintegrating Tablet Excipient Sales by Type
  6. 5.2.1 Global Orally Disintegrating Tablet Excipient Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Orally Disintegrating Tablet Excipient Sales by Type (2021-2032) & (K MT)
  8. 5.2.3 Global Orally Disintegrating Tablet Excipient Sales Market Share by Type (2021-2032)
  9. 5.3 Global Orally Disintegrating Tablet Excipient Price by Type
6 Orally Disintegrating Tablet Excipient Market by Application
  1. 6.1 Global Orally Disintegrating Tablet Excipient Revenue by Application
  2. 6.1.1 Global Orally Disintegrating Tablet Excipient Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Orally Disintegrating Tablet Excipient Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Orally Disintegrating Tablet Excipient Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Orally Disintegrating Tablet Excipient Sales by Application
  6. 6.2.1 Global Orally Disintegrating Tablet Excipient Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Orally Disintegrating Tablet Excipient Sales by Application (2021-2032) & (K MT)
  8. 6.2.3 Global Orally Disintegrating Tablet Excipient Sales Market Share by Application (2021-2032)
  9. 6.3 Global Orally Disintegrating Tablet Excipient Price by Application
7 Company Profiles
  1. 7.1 BASF
  2. 7.1.1 BASF Company Information
  3. 7.1.2 BASF Business Overview
  4. 7.1.3 BASF Orally Disintegrating Tablet Excipient Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 BASF Orally Disintegrating Tablet Excipient Product Portfolio
  6. 7.1.5 BASF Recent Developments
  7. 7.2 JRS Pharma
  8. 7.2.1 JRS Pharma Company Information
  9. 7.2.2 JRS Pharma Business Overview
  10. 7.2.3 JRS Pharma Orally Disintegrating Tablet Excipient Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 JRS Pharma Orally Disintegrating Tablet Excipient Product Portfolio
  12. 7.2.5 JRS Pharma Recent Developments
  13. 7.3 Roquette
  14. 7.3.1 Roquette Company Information
  15. 7.3.2 Roquette Business Overview
  16. 7.3.3 Roquette Orally Disintegrating Tablet Excipient Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Roquette Orally Disintegrating Tablet Excipient Product Portfolio
  18. 7.3.5 Roquette Recent Developments
  19. 7.4 ABF Ingredients
  20. 7.4.1 ABF Ingredients Company Information
  21. 7.4.2 ABF Ingredients Business Overview
  22. 7.4.3 ABF Ingredients Orally Disintegrating Tablet Excipient Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 ABF Ingredients Orally Disintegrating Tablet Excipient Product Portfolio
  24. 7.4.5 ABF Ingredients Recent Developments
  25. 7.5 DFE Pharma
  26. 7.5.1 DFE Pharma Company Information
  27. 7.5.2 DFE Pharma Business Overview
  28. 7.5.3 DFE Pharma Orally Disintegrating Tablet Excipient Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 DFE Pharma Orally Disintegrating Tablet Excipient Product Portfolio
  30. 7.5.5 DFE Pharma Recent Developments
  31. 7.6 Evonik
  32. 7.6.1 Evonik Company Information
  33. 7.6.2 Evonik Business Overview
  34. 7.6.3 Evonik Orally Disintegrating Tablet Excipient Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Evonik Orally Disintegrating Tablet Excipient Product Portfolio
  36. 7.6.5 Evonik Recent Developments
  37. 7.7 Merck KGaA
  38. 7.7.1 Merck KGaA Company Information
  39. 7.7.2 Merck KGaA Business Overview
  40. 7.7.3 Merck KGaA Orally Disintegrating Tablet Excipient Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Merck KGaA Orally Disintegrating Tablet Excipient Product Portfolio
  42. 7.7.5 Merck KGaA Recent Developments
  43. 7.8 Ashland
  44. 7.8.1 Ashland Company Information
  45. 7.8.2 Ashland Business Overview
  46. 7.8.3 Ashland Orally Disintegrating Tablet Excipient Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Ashland Orally Disintegrating Tablet Excipient Product Portfolio
  48. 7.8.5 Ashland Recent Developments
  49. 7.9 Meggle Pharma
  50. 7.9.1 Meggle Pharma Company Information
  51. 7.9.2 Meggle Pharma Business Overview
  52. 7.9.3 Meggle Pharma Orally Disintegrating Tablet Excipient Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Meggle Pharma Orally Disintegrating Tablet Excipient Product Portfolio
  54. 7.9.5 Meggle Pharma Recent Developments
  55. 7.10 Shin-Etsu
  56. 7.10.1 Shin-Etsu Company Information
  57. 7.10.2 Shin-Etsu Business Overview
  58. 7.10.3 Shin-Etsu Orally Disintegrating Tablet Excipient Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Shin-Etsu Orally Disintegrating Tablet Excipient Product Portfolio
  60. 7.10.5 Shin-Etsu Recent Developments
  61. 7.11 Fuji Chemical Industries
  62. 7.11.1 Fuji Chemical Industries Company Information
  63. 7.11.2 Fuji Chemical Industries Business Overview
  64. 7.11.3 Fuji Chemical Industries Orally Disintegrating Tablet Excipient Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Fuji Chemical Industries Orally Disintegrating Tablet Excipient Product Portfolio
  66. 7.11.5 Fuji Chemical Industries Recent Developments
  67. 7.12 McePharma (Vivesa holding)
  68. 7.12.1 McePharma (Vivesa holding) Company Information
  69. 7.12.2 McePharma (Vivesa holding) Business Overview
  70. 7.12.3 McePharma (Vivesa holding) Orally Disintegrating Tablet Excipient Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 McePharma (Vivesa holding) Orally Disintegrating Tablet Excipient Product Portfolio
  72. 7.12.5 McePharma (Vivesa holding) Recent Developments
  73. 7.13 Cargill Incorporated
  74. 7.13.1 Cargill Incorporated Company Information
  75. 7.13.2 Cargill Incorporated Business Overview
  76. 7.13.3 Cargill Incorporated Orally Disintegrating Tablet Excipient Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Cargill Incorporated Orally Disintegrating Tablet Excipient Product Portfolio
  78. 7.13.5 Cargill Incorporated Recent Developments
  79. 7.14 Daicel Corporation
  80. 7.14.1 Daicel Corporation Company Information
  81. 7.14.2 Daicel Corporation Business Overview
  82. 7.14.3 Daicel Corporation Orally Disintegrating Tablet Excipient Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 Daicel Corporation Orally Disintegrating Tablet Excipient Product Portfolio
  84. 7.14.5 Daicel Corporation Recent Developments
  85. 7.15 Anhui Sunhere Pharmaceutical
  86. 7.15.1 Anhui Sunhere Pharmaceutical Company Information
  87. 7.15.2 Anhui Sunhere Pharmaceutical Business Overview
  88. 7.15.3 Anhui Sunhere Pharmaceutical Orally Disintegrating Tablet Excipient Sales, Revenue, Price and Gross Margin (2021-2026)
  89. 7.15.4 Anhui Sunhere Pharmaceutical Orally Disintegrating Tablet Excipient Product Portfolio
  90. 7.15.5 Anhui Sunhere Pharmaceutical Recent Developments
8 North America
  1. 8.1 North America Orally Disintegrating Tablet Excipient Market Size by Type
  2. 8.1.1 North America Orally Disintegrating Tablet Excipient Revenue by Type (2021-2032)
  3. 8.1.2 North America Orally Disintegrating Tablet Excipient Sales by Type (2021-2032)
  4. 8.1.3 North America Orally Disintegrating Tablet Excipient Price by Type (2021-2032)
  5. 8.2 North America Orally Disintegrating Tablet Excipient Market Size by Application
  6. 8.2.1 North America Orally Disintegrating Tablet Excipient Revenue by Application (2021-2032)
  7. 8.2.2 North America Orally Disintegrating Tablet Excipient Sales by Application (2021-2032)
  8. 8.2.3 North America Orally Disintegrating Tablet Excipient Price by Application (2021-2032)
  9. 8.3 North America Orally Disintegrating Tablet Excipient Market Size by Country
  10. 8.3.1 North America Orally Disintegrating Tablet Excipient Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Orally Disintegrating Tablet Excipient Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Orally Disintegrating Tablet Excipient Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Orally Disintegrating Tablet Excipient Market Size by Type
  2. 9.1.1 Europe Orally Disintegrating Tablet Excipient Revenue by Type (2021-2032)
  3. 9.1.2 Europe Orally Disintegrating Tablet Excipient Sales by Type (2021-2032)
  4. 9.1.3 Europe Orally Disintegrating Tablet Excipient Price by Type (2021-2032)
  5. 9.2 Europe Orally Disintegrating Tablet Excipient Market Size by Application
  6. 9.2.1 Europe Orally Disintegrating Tablet Excipient Revenue by Application (2021-2032)
  7. 9.2.2 Europe Orally Disintegrating Tablet Excipient Sales by Application (2021-2032)
  8. 9.2.3 Europe Orally Disintegrating Tablet Excipient Price by Application (2021-2032)
  9. 9.3 Europe Orally Disintegrating Tablet Excipient Market Size by Country
  10. 9.3.1 Europe Orally Disintegrating Tablet Excipient Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Orally Disintegrating Tablet Excipient Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Orally Disintegrating Tablet Excipient Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Orally Disintegrating Tablet Excipient Market Size by Type
  2. 10.1.1 China Orally Disintegrating Tablet Excipient Revenue by Type (2021-2032)
  3. 10.1.2 China Orally Disintegrating Tablet Excipient Sales by Type (2021-2032)
  4. 10.1.3 China Orally Disintegrating Tablet Excipient Price by Type (2021-2032)
  5. 10.2 China Orally Disintegrating Tablet Excipient Market Size by Application
  6. 10.2.1 China Orally Disintegrating Tablet Excipient Revenue by Application (2021-2032)
  7. 10.2.2 China Orally Disintegrating Tablet Excipient Sales by Application (2021-2032)
  8. 10.2.3 China Orally Disintegrating Tablet Excipient Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Orally Disintegrating Tablet Excipient Market Size by Type
  2. 11.1.1 Asia Orally Disintegrating Tablet Excipient Revenue by Type (2021-2032)
  3. 11.1.2 Asia Orally Disintegrating Tablet Excipient Sales by Type (2021-2032)
  4. 11.1.3 Asia Orally Disintegrating Tablet Excipient Price by Type (2021-2032)
  5. 11.2 Asia Orally Disintegrating Tablet Excipient Market Size by Application
  6. 11.2.1 Asia Orally Disintegrating Tablet Excipient Revenue by Application (2021-2032)
  7. 11.2.2 Asia Orally Disintegrating Tablet Excipient Sales by Application (2021-2032)
  8. 11.2.3 Asia Orally Disintegrating Tablet Excipient Price by Application (2021-2032)
  9. 11.3 Asia Orally Disintegrating Tablet Excipient Market Size by Country
  10. 11.3.1 Asia Orally Disintegrating Tablet Excipient Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Orally Disintegrating Tablet Excipient Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Orally Disintegrating Tablet Excipient Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Orally Disintegrating Tablet Excipient Market Size by Type
  2. 12.1.1 SAMEA Orally Disintegrating Tablet Excipient Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Orally Disintegrating Tablet Excipient Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Orally Disintegrating Tablet Excipient Price by Type (2021-2032)
  5. 12.2 SAMEA Orally Disintegrating Tablet Excipient Market Size by Application
  6. 12.2.1 SAMEA Orally Disintegrating Tablet Excipient Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Orally Disintegrating Tablet Excipient Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Orally Disintegrating Tablet Excipient Price by Application (2021-2032)
  9. 12.3 SAMEA Orally Disintegrating Tablet Excipient Market Size by Country
  10. 12.3.1 SAMEA Orally Disintegrating Tablet Excipient Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Orally Disintegrating Tablet Excipient Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Orally Disintegrating Tablet Excipient Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Orally Disintegrating Tablet Excipient Value Chain Analysis
  2. 13.1.1 Orally Disintegrating Tablet Excipient Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Orally Disintegrating Tablet Excipient Production Mode & Process
  6. 13.2 Orally Disintegrating Tablet Excipient Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Orally Disintegrating Tablet Excipient Distributors
  9. 13.2.3 Orally Disintegrating Tablet Excipient Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst